Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein transport protein Sec61 subunit alpha isoform 2 (SEC61A2) is a core component of the SEC61 channel-forming translocon complex within the endoplasmic reticulum (ER)[1][9][10]. This complex mediates the **translocation of signal peptide–containing precursor polypeptides** across the ER membrane—an essential, conserved process in protein biosynthesis and membrane assembly[2][3][6]. SEC61A2, alongside its paralog SEC61A1, forms the protein-conducting channel with the capacity to function as a major **ribosome receptor and a gated pore**, enabling both co- and post-translational import of polypeptides into the ER[1][2][7]. The channel also provides a route for passive calcium ion (Ca²⁺) leakage from the ER, influencing cellular calcium homeostasis[2]. SEC61A2's role is particularly critical in pancreatic β-cells, where it impacts proinsulin biosynthesis and thereby glucose regulation[5]. Dysfunction of SEC61A2—by mutation, suppression, or pharmacologic inhibition—has been linked to congenital neutropenia, diabetes, and cancer pathogenesis, making it a potential therapeutic target, though safety concerns are extensive given its central cellular function[2][5].
Inhibition of protein translocation by blocking the Sec61 channel function (prevents passage of nascent polypeptides into ER, impairs secretory pathway proteins) Disruption of ER calcium homeostasis via Ca²⁺ leak
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein transport protein Sec61 subunit alpha isoform 2 (SEC61A2).